Haofei Hu
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet, Metabolism, and Disease
- Diabetes Treatment and Management
- Diabetes Management and Research
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
- Nephrology 30
- Chronic Kidney Disease and Diabetes 17
- Renal Diseases and Glomerulopathies 16
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 39
- Diabetes Management and Research 10
- Diabetes Treatment and Management 10
Haofei Hu
107 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Endocrinology, Diabetes and Metabolism 482
- Nephrology 139
- Epidemiology 413
- Cardiology and Cardiovascular Medicine 188
- Hepatology 44
Countries citing papers authored by Haofei Hu
This map shows the geographic impact of Haofei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haofei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haofei Hu more than expected).
Fields of papers citing papers by Haofei Hu
This network shows the impact of papers produced by Haofei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haofei Hu. The network helps show where Haofei Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haofei Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 5 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 23 | |
| 12 | 2023 | 30 | |
| 13 | 2023 | 6 | |
| 14 | 2022 | 6 | |
| 15 | 2022 | 6 | |
| 16 | 2022 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2020 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2014 | 9 |
About Haofei Hu
Haofei Hu is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Epidemiology, Cardiology and Cardiovascular Medicine and Hepatology, having authored 127 papers that have together received 1.0k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (39 papers), Liver Disease Diagnosis and Treatment (28 papers), Chronic Kidney Disease and Diabetes (17 papers), Renal Diseases and Glomerulopathies (16 papers), Lipoproteins and Cardiovascular Health (14 papers), Diabetes Management and Research (10 papers), Diabetes Treatment and Management (10 papers) and Cardiac, Anesthesia and Surgical Outcomes (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (482 citations), Nephrology (139 citations), Epidemiology (413 citations), Cardiology and Cardiovascular Medicine (188 citations) and Hepatology (44 citations). Haofei Hu has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Yong Han, Changchun Cao, Qijun Wan, Yongcheng He, Xiaodan Zheng, Qiming Li, Yufei Liu, Li‐Ling Wu, Yang Wu and Xin Zuo. Their work appears in journals such as Frontiers in Endocrinology, Scientific Reports, BMC Neurology, Frontiers in Medicine and Diabetology & Metabolic Syndrome.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.